Skip to main content
profile image
Selected Works of Philip Mease, MD
Article
185 Secukinumab demonstrates consistent safety over long-term exposure in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses
Rheumatology (2018)
  • Iain McInnes, University of Glasgow
  • Philip Mease, University of Washington
  • Kristian Reich, University of Göttingen
  • Peter Nash, University of Queensland
  • Mats Andersson, Novartis
  • Ken Abrams, Novartis
  • Luminita Pricop, Novartis
  • Todd Fox, Novartis
Link
Disciplines
Publication Date
April 1, 2018
DOI
10.1093/rheumatology/key075.409
Citation Information
Iain McInnes, Philip Mease, Kristian Reich, Peter Nash, et al.. "185 Secukinumab demonstrates consistent safety over long-term exposure in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses" Rheumatology Vol. 57 (2018)
Available at: http://works.bepress.com/philip-mease/5/